SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 38.12 |
Enterprise Value ($M) | 32.65 |
Book Value ($M) | -9.98 |
Book Value / Share | -0.30 |
Price / Book | -3.82 |
NCAV ($M) | -10.80 |
NCAV / Share | -0.32 |
Price / NCAV | -3.53 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | -6.13 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.39 |
Current Ratio | 0.39 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 6.81 |
Assets | 7.63 |
Liabilities | 17.61 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Armistice Capital, Llc | 9.99 | 90.36 | |
13G | Schonfeld Strategic Advisors LLC | 5.30 | ||
13D/A | Bhat Laxminarayan | 8.60 | 0.29 | |
13D/A | Saxena Parag | 16.90 | ||
13G | Integrated Core Strategies (us) Llc | 5.20 | ||
13D/A | Vedanta Partners, Llc | 18.50 | -2.39 | |
13G/A | Tang Capital Partners Lp | 9.99 | 36.73 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
81,789 | 268,487 | 30.46 | |
173,606 | 539,679 | 32.17 | |
108,992 | 443,244 | 24.59 | |
35,531 | 411,768 | 8.63 | |
(click for more detail) |
Similar Companies | |
---|---|
RMTI – Rockwell Medical, Inc. | RNAZ – TransCode Therapeutics, Inc. |
RNXT – RenovoRx, Inc. | RZLT – Rezolute, Inc. |
SABS – SAB Biotherapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io